Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.80%
#2 Mubarak Mubarak +36.45%
#3 Pons Pons +36.32%
#4 Starpower Starpower +34.59%
#5 Bitway Bitway +31.78%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.19%
#7 TENDIES TENDIES +25.97%
#8 Ocean Protocol Ocean Protocol +24.85%
#9 SkyAI SkyAI +24.01%
#10 StonkBroker StonkBroker +21.30%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
ABVC BioPharma, Inc. ABVC BioPharma, Inc.

ABVC BioPharma, Inc.

ABVC
Helyezés a részvények között #28867
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on... ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Részvényárfolyam
$0.9201
Piaci kapitalizáció
$23.92M
Változás (1 nap)
6.23%
Változás (1 év)
-67.72%
Ország
US
Kereskedés ABVC BioPharma, Inc. (ABVC)

Kategória

Healthcare
ABVC BioPharma, Inc. (ABVC) részvényárfolyamának története
Legmagasabb napi záróár: $0.94 ekkor: 2026-08-01

Legalacsonyabb napi záróár: $455.54K ekkor: 2004-11-01
ABVC BioPharma, Inc. részvényárfolyamának története 2004 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2026 (TTM) -15.73%
2025 331.39%
2024 -56.69%
2023 -82.53%
2022 -79.50%
2021 -27.15%
2020 -18.60%
2019 -79.88%
2018 -21.05%
2017 0.00%
2016 -74.88%
2015 -42.11%
2014 -17.94%
2013 -48.16%
2012 -81.81%
2011 -12.18%
2010 -91.16%
2009 -58.61%
2008 -66.11%
2007 -5.25%
2006 160.11%
2005 191.95%
2004 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.79 38.90%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 55.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $142.08 409.08%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 8.59%
CH